ScreenerHero

XOMAXOMA Corporation

NAS · US · Healthcare · Biotechnology · xoma.com
40.17USD0.00%Mkt Cap: 710.16M $P/E: 25.59

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty paymen…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap710.16M $
Enterprise Value562.48M $
Revenue (TTM)48.55M $
Gross Profit48.09M $
Net Income (TTM)31.71M $
Revenue/Share4.025 USD
Last Price40.17 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)25.59
P/E (Forward)18.77
PEG—
EV/EBITDA67.81
EV/Revenue11.58
P/S14.63
P/B5.15
EPS (TTM)1.57
EPS (Forward)2.14
52W Range
22.2978% of range45.20
52W High45.20 USD
52W Low22.29 USD
Profitability
Gross Margin99.04%
Oper. Margin-3.90%
EBITDA Margin17.08%
Profit Margin271.97%
ROE37.78%
ROA11.63%
Growth
Revenue Growth-22.60%
Earnings Growth207.90%
Cash Flow & Leverage
Operating CF2.87M $
CapEx (TTM)20.73M $
FCF Margin-26.92%
FCF Yield-1.84%
Net Debt38.64M $
Net Debt/EBITDA4.66
Balance Sheet
Debt/Equity1.57
Current Ratio3.59
Quick Ratio3.31
Book Value/Sh7.794 USD
Cash/Share6.865 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJan 3, 2025
Pay Date—
Splits
Last Split1:20
Split DateOct 18, 2016
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)39.00 USD
Upside (mean)-2.9%
Target Range39.00 USD – 39.00 USD
# Analysts1
Ownership
Shares Out.17.68M
Float4.80M
Insiders2.33%
Institutions85.33%
Short Interest
Short Ratio6.4d
Short % Float9.29%
Short % Out.5.18%
Shares Short914.94K
Short (prev mo.)852.05K
Technical
SMA 5041.95 (-4.2%)
SMA 20033.57 (+19.7%)
Beta0.86
S&P 52W Chg18.16%
Avg Vol (30d)258.87K
Avg Vol (10d)763.86K
Technical Indicators
RSI (14)35.3
MACD-0.4150
MACD Signal-0.0430
MACD Hist.-0.3720
BB Upper45.01 USD
BB Middle41.93 USD
BB Lower38.86 USD
BB Width14.66%
ATR (14)0.5578 USD
Vol Ratio (20d)0.00x